Moussa, M., Riad, S., Omar, E., Abdelhamid, H., Afifi, M., Mourad, G., Mehanna, R. (2023). STUDYING THE APOPTOTIC AND NECROTIC CELLS OUTCOMES UPON TARGETING ORAL SQUAMOUS CELL CARCINOMA WITH TOLL LIKE RECEPTOR 7 AGONIST (IMIQUIMOD): IN- VITRO AND IN- VIVO STUDY. test, 47(4), 8-8. doi: 10.21608/adjalexu.2022.273527
Magi N. Moussa; Sahar M. Riad; Enas M. Omar; Hend M. Abdelhamid; Marwa M. Afifi; Ghada M. Mourad; Radwa A. Mehanna. "STUDYING THE APOPTOTIC AND NECROTIC CELLS OUTCOMES UPON TARGETING ORAL SQUAMOUS CELL CARCINOMA WITH TOLL LIKE RECEPTOR 7 AGONIST (IMIQUIMOD): IN- VITRO AND IN- VIVO STUDY". test, 47, 4, 2023, 8-8. doi: 10.21608/adjalexu.2022.273527
Moussa, M., Riad, S., Omar, E., Abdelhamid, H., Afifi, M., Mourad, G., Mehanna, R. (2023). 'STUDYING THE APOPTOTIC AND NECROTIC CELLS OUTCOMES UPON TARGETING ORAL SQUAMOUS CELL CARCINOMA WITH TOLL LIKE RECEPTOR 7 AGONIST (IMIQUIMOD): IN- VITRO AND IN- VIVO STUDY', test, 47(4), pp. 8-8. doi: 10.21608/adjalexu.2022.273527
Moussa, M., Riad, S., Omar, E., Abdelhamid, H., Afifi, M., Mourad, G., Mehanna, R. STUDYING THE APOPTOTIC AND NECROTIC CELLS OUTCOMES UPON TARGETING ORAL SQUAMOUS CELL CARCINOMA WITH TOLL LIKE RECEPTOR 7 AGONIST (IMIQUIMOD): IN- VITRO AND IN- VIVO STUDY. test, 2023; 47(4): 8-8. doi: 10.21608/adjalexu.2022.273527